Citeline Podcasts
Episodes
Scrip's Five Must-Know Things - July 14, 2025
14 Jul 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 11, 2025. In this episode: Merck & Co’s Verona acq...
Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette
14 Jul 2025
Contributed by Lukas
Originally developed to treat diabetes, GLP-1 agonists have been found to suppress appetite and reduce calorie intake, fueling their growing popularit...
바이오 USA: 금융 시장 스트레스, 딜메이킹 기회 창출 (Korean-language podcast)
11 Jul 2025
Contributed by Lukas
올해 제약바이오 M&A 가 다소 주춤할 것으로 전망되고 있지만, 재정난을 겪고 있는 의약품 개발업체들이 자금조달...
Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines
09 Jul 2025
Contributed by Lukas
The latest episode of the In Vivo podcast features an interview with Phil L'Huillier, who discusses the inclusion of Scancell's melanoma cancer vaccin...
Acuitas CSO on CRISPR Delivery Breakthrough and Innovations in Lipid Nanoparticles
07 Jul 2025
Contributed by Lukas
Ying Tam, Chief Scientific Officer at Acuitas Therapeutics, discusses the company's role in delivering the first personalized CRISPR gene editing trea...
Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators
07 Jul 2025
Contributed by Lukas
The latest episode of the In Vivo podcast features an conversation with Agnès Arbat, CEO and co-founder of Barcelona-based biotech company OxoLife, w...
How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke
07 Jul 2025
Contributed by Lukas
According to a recently published study by Bayer Consumer Health, being poor makes it more likely that you will suffer from self-treatable health cond...
Scrip's Five Must-Know Things - July 7, 2025
07 Jul 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 4, 2025. In this episode: AbbVie’s big autoimmune ...
【3分で解説 世界のファーマ】第24回 トランプ関税 製薬大国インドへの影響 (Japanese-language podcast)
03 Jul 2025
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
ADDF's Karen Harris: Investing in Alzheimer's Like a VC
02 Jul 2025
Contributed by Lukas
How is venture philanthropy revolutionizing Alzheimer's drug discovery? We sit down with Karen Harris, CFO at the Alzheimer's Drug Discovery Foundatio...
China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss
02 Jul 2025
Contributed by Lukas
In the first episode of this new China Biopharma English-language mini podcast, Shanghai-based senior reporter Xu Hu looks at the main directions in w...
Datamonitor Healthcare Podcast: ASCO 2025
30 Jun 2025
Contributed by Lukas
Summer Colling and Emma Wille speak with oncology experts Nkiru Ibeanu, Neha Anand, Anna Simmons and David Dahan about the 2025 American Society of Cl...
Master Regulatory Hurdles and Accelerate Your Drug Development
30 Jun 2025
Contributed by Lukas
With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing rea...
Scrip's Five Must-Know Things - June 30, 2025
30 Jun 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended June 27, 2025. In this episode: top drugs in the first qu...
Post-BIO Podcast: Thoughts From The Frontlines
26 Jun 2025
Contributed by Lukas
Join Scrip editors Mandy Jackson and Mary Jo Laffler and Pink Sheet editor Sarah Karlin-Smith as they discuss the general mood at the recent BIO Inter...
Navigating Regulatory Uncertainty: Diversity Action Plans
24 Jun 2025
Contributed by Lukas
The FDA’s Diversity Action Plan guidance underwent several changes in recent months—with the draft guidance taken down, restored, and then pulled ...
How to Crush Competitive Threats and Stand Out in Biotech
23 Jun 2025
Contributed by Lukas
The race for new therapies is more intense than ever. This episode uncovers how biotech and pharma use competitive intelligence, AI, and data to outsm...
Scrip's Five Must-Know Things - June 23, 2025
23 Jun 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended June 20, 2025. In this episode: US policies in spotlight ...
유럽 바이오기업, 자금조달의 현주소는? (Korean-language podcast)
17 Jun 2025
Contributed by Lukas
관세와 무역 장벽의 출현, 정책 변화 등으로 올해 유럽 바이오기업들의 자금조달이 쉽지 않은 상황이라는 In Vivo 기...
Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients
16 Jun 2025
Contributed by Lukas
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and ...
Unpacking EU Omnibus And Its Impact On Sustainability: With CEN Group’s Jasper Crone
16 Jun 2025
Contributed by Lukas
The European Commission has put forward a series of proposals designed to simplify European Union sustainability rules and boost the region’s compet...
Scrip's Five Must-Know Things - 16 June 2025
16 Jun 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 13 June 2025. In this episode: breaking down big pharma’...
Drug Fix: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing
13 Jun 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Francesca Bruce, Senior Editor Cathy Kelly and Editor-in-Chief Nielsen Hobbs consider Europ...
Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)
12 Jun 2025
Contributed by Lukas
The 14 July entry deadline for the Citeline Japan Awards 2025 in Tokyo on 21 October is fast approaching! Join Ian Haydock and Lisa Takagi in this bil...
Strategies to Secure Critical Biotech Funding Amid Market Challenges
11 Jun 2025
Contributed by Lukas
Biotechs are racing to change the rules in this tough market. This episode reveals how AI, real-world data, and strategic partnerships are reshaping d...
How to Survive Innovation Pressure in Today’s Biotech Landscape
11 Jun 2025
Contributed by Lukas
Small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resil...
Scrip's Five Must-Know Things - 9 June 2025
09 Jun 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 June 2025. In this episode: Sanofi’s Blueprint buy; A...
Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts
06 Jun 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss why ...
A Deep Dive into Sjögren's Disease
06 Jun 2025
Contributed by Lukas
Summer Colling speaks with Emma Wille about the symptoms, diagnosis, and treatment landscape of Sjögren’s disease, highlighting the latest research...
Digital Health Roundup: Synchron Syncs With Apple, Ketryx’s AI Agents, AdvaMed’s AI RoadMap
04 Jun 2025
Contributed by Lukas
In this week's Digital Health Roundup, MedTech Insight's Shubham Singh explores how Ketryx's launch of validated AI agents could reshape compliance au...
Raj Panjabi on Flagship's Preemptive Health and Medicine Initiative
03 Jun 2025
Contributed by Lukas
Flagship Pioneering senior partner Raj Panjabi discusses shifting healthcare from reactive treatment to AI-powered prediction and prevention of diseas...
SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases
03 Jun 2025
Contributed by Lukas
SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases by Citeline
Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer
03 Jun 2025
Contributed by Lukas
Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer by Citeline
The Generics Bulletin Podcast: The Global Generics & Biosimilars Awards 2025
03 Jun 2025
Contributed by Lukas
Generics Bulletin editors Dave Wallace and Dean Rudge discuss the Global Generics & Biosimilars Awards 2025, providing all the key details of the even...
Podcast: Navigating the Future of Hepatology Clinical Trials
02 Jun 2025
Contributed by Lukas
Join Andrew Warmington, Manufacturing Editor at Citeline, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full...
Innovation & Integrity: The Dual Path to Success for Device Makers
02 Jun 2025
Contributed by Lukas
An expert from ISACA shares her insights into medtech’s Voluntary Improvement Program (VIP), a collaboration among participants, ISACA, MDIC, and US...
Driving Innovation And Growth In France’s Self-Care Market, With Neres Luc Besançon
02 Jun 2025
Contributed by Lukas
Largely driven by community pharmacy footfall, France’s self-care market is dynamic and characterized by high levels of innovation, according to Fre...
Scrip's Five Must-Know Things - 2 June 2025
02 Jun 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 May 2025. In this episode: a preview of major ASCO rea...
Drug Fix: US FDA’s Private Pharma CEO Tour, HHS Changes COVID-19 Vaccine Recommendation
30 May 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the...
FDA in Transition: How Regulatory Shifts Are Redefining Drug Development
27 May 2025
Contributed by Lukas
The uncertainty surrounding changes at the FDA and other market dynamics is reshaping the global drug development landscape. In this webinar, CRO regu...
Scrip's Five Must-Know Things - 26 May 2025
26 May 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 May 2025. In this episode: Novo Nordisk’s CEO forced...
Drug Fix: US FDA’s Big Vaccine Policy Week
23 May 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the...
“Powerful Yet Unexplored”: Commit Biologics Tackles The Complement System
20 May 2025
Contributed by Lukas
Mikkel Wandahl Pederson, CEO and chief scientific officer at Commit Biologics, discussed the company’s mission to harness the powerful complement sy...
제약바이오딜 투자수익률 하락…시장 불안정으로 상황 악화될 수도 (Korean-language podcast)
20 May 2025
Contributed by Lukas
바이오기업 가치상승으로 일부 딜 (deal)의 경우 빅파마의 투자수익률 (ROI)이 거의 없는 상황이지만, 특정 전략으로...
Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer
20 May 2025
Contributed by Lukas
While few doubt the opportunity represented by real-world evidence, some concerns remain about its validity compared to traditional forms of clinical ...
Scrip's Five Must-Know Things - 19 May 2025
19 May 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 May 2025. In this episode: Trump’s executive order m...
China Biopharma Podcast - 14 May 2025 (Chinese language)
14 May 2025
Contributed by Lukas
在本期中国生物技术播客中，Dexter Yan回顾了他在4月的美国癌症研究协会年会（AACR）举办前和再鼎医药总裁及全球...
Scrip's Five Must-Know Things - 12 May 2025
12 May 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 May 2025. In this episode: industry makes its case to T...
Drug Fix: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns
09 May 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider early excitement and concern about Vi...
Scrip's Five Must-Know Things - 7 May 2025
07 May 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 May 2025. In this episode: AstraZeneca CEO cautions Eur...
Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer
06 May 2025
Contributed by Lukas
The potential for real world evidence (RWE) is huge, according to enthusiasts, but to the uninitiated it can seem like a complicated and forbidding su...
OPPI’s Matai On India’s IPR Regime: Progress, Pain Points, Possibilities
05 May 2025
Contributed by Lukas
Anil Matai, director general, Organization of Pharmaceutical Producers of India, discusses the evolving intellectual property landscape in India post ...
Drug Fix: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?
02 May 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor in Chief Nielsen Hobbs consider the...
Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
01 May 2025
Contributed by Lukas
Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Ala...
Conference Catch-Up: BIO-Europe 2025
01 May 2025
Contributed by Lukas
In this episode, we recap the key takeaways from BIO-Europe 2025, held in Milan, Italy, in March 2025, with Trajko Spasenovski, Vice President of Stra...
Highlights from AAN 2025
30 Apr 2025
Contributed by Lukas
Emma Wille and Summer Colling discuss the 2025 American Academy of Neurology (AAN) conference with CNS and I&I analysts Wen-Yu Huang, Joseph Jacob and...
Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs
29 Apr 2025
Contributed by Lukas
Aragen Life Sciences’s CEO Manni Kantipudi - also former CIO of Intel Asia - speaks with Citeline’s senior editor Vibha Ravi about the changing gl...
Scrip's Five Must-Know Things - 28 April 2025
28 Apr 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 April 2025. In this episode: 2024’s top-selling drug...
Drug Fix: More US FDA Departures, Makary On Combined AE Database, ‘Conditional’ Approval
25 Apr 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Senior Editor Sue Sutter discuss the impact of the departures of sev...
Precision Medicine in Liver Treatment: The Ochre Bio Approach
23 Apr 2025
Contributed by Lukas
Ochre Bio co-founder and CSO Quin Wills spoke with In Vivo about the UK-based company's novel approach to finding and validating RNA therapies for chr...
Scrip's Five Must-Know Things - 21 April 2025
21 Apr 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 April 2025. In this episode: Trump’s drug pricing ex...
Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls
18 Apr 2025
Contributed by Lukas
Summary: At the heart of any successful self-care business is a portfolio of recognizable and trusted consumer health brands. These brands could play ...
Scrip's Five Must-Know Things - 14 April 2025
14 Apr 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 April 2025. In this episode: Trump’s tariff rollerco...
미국 관세 롤러코스터에 제약업계는 여전히 불안 (Korean-language podcast)
11 Apr 2025
Contributed by Lukas
미국이 수입 의약품에 관세를 부과할 가능성은 여전하지만, 트럼프의 최근 발표로 인해 이를 시행하는 데 시간이...
Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls
07 Apr 2025
Contributed by Lukas
Exerting maximum influence on stakeholders, helping companies navigate regulatory complexity and promoting industry best practice are three big jobs t...
Scrip's Five Must-Know Things - 7 April 2025
07 Apr 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 4 April 2025. In this episode: pharma dodges tariffs for ...
Drug Fix: Understanding The US FDA Reduction-In-Force And Its Long-Term Impact
04 Apr 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the...
CEO Nicolas Poirier on OSE Immunotherapeutics Latest IL-7 Data
03 Apr 2025
Contributed by Lukas
OSE Immunotherapeutics' CEO Nicolas Poirier talks about the company's IL-7 receptor agonist, lusvertikimab, recent data presented at The European Croh...
Digital Health Roundup: Intuitive CEO Exec Chat, Patient Monitoring, Exer Labs Woes, Roche New NGS Prototype
02 Apr 2025
Contributed by Lukas
In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights her interview with Gary Guthart, CEO of Intuitive Surgical about t...
Scrip's Five Must-Know Things - 31 March 2025
31 Mar 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 March 2025. In this episode: Merck & Co. licenses Heng...
Drug Fix: Understanding The Impact Of The Latest HHS Layoffs On The US FDA
28 Mar 2025
Contributed by Lukas
Introduction: Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, and Senior Editor Sue Sutter discuss the impact of the 3,...
Innovative Oncology, A Conversation with iOnctura
28 Mar 2025
Contributed by Lukas
In Vivo spoke with UK biotech CEO Catherine Pickering about developing innovative therapies for challenging cancer types, the progress of iOntura's le...
Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”
26 Mar 2025
Contributed by Lukas
Farideh Bischoff, chief medical officer of Heranova Lifesciences, discusses the urgent need for better diagnostic options and the latest innovations t...
What To Expect From The 61st AESGP Annual Meeting, With AESGP’s Jurate Švarcaite
24 Mar 2025
Contributed by Lukas
Europe’s self-care industry leaders, policymakers and stakeholders are heading to Warsaw, Poland between the 4th and 6th June this year for the Asso...
Scrip's Five Must-Know Things - 24 March 2025
24 Mar 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 March 2025. In this episode: Pfizer tops pharma leader...
Drug Fix: US FDA Productivity Complaints Emerge, Internal Return To Office Headaches
21 Mar 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss industry stakeholders’ compl...
Scrip's Five Must-Know Things - 17 March 2025
17 Mar 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 March 2025. In this episode: Roche’s big new obesity...
Drug Fix: Buyouts, Departures and Other US FDA Chaos
14 Mar 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the US Food and Drug Administr...
The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US
11 Mar 2025
Contributed by Lukas
Generics Bulletin editors Dave Wallace and Dean Rudge discuss the latest updates on Stelara (ustekinumab) biosimilars in the US, including recent laun...
Scrip M&A Podcast: Looking at M&A activity as Q1 2025 nears a close.
11 Mar 2025
Contributed by Lukas
Scrip senior writer Joseph Haas discusses the latest biopharmaceutical merger-and-acquisition activity and trends with attorneys Jessica Bisignano and...
Vaccines, Viruses & Variants: The State of COVID-19 & Flu in 2025
11 Mar 2025
Contributed by Lukas
Summer Colling and Emma Wille speak with Datamonitor Healthcare's infectious disease analysts Charlotte Holmes and Natasha Boliter to discuss the late...
Scrip's Five Must-Know Things - 10 March 2025
10 Mar 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 March 2025. In this episode: low-cost Wegovy an alterna...
Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell
10 Mar 2025
Contributed by Lukas
Summary: The UK’s Maxwellia has been on quite a journey, from “switch-in-a-box” start-up to a consumer healthcare company in its own right, laun...
Grove AI and Grace, An Agentic AI For Clinical Trial Engagement
07 Mar 2025
Contributed by Lukas
In Vivo spoke with Tran Le and Sohit Gatiganti, co-founders of Grove AI and developers of Grace, a voice-based agentic AI that streamlines clinical tr...
Drug Fix: What We Learned From US FDA Commissioner Nominee Makary’s Confirmation Hearing?
07 Mar 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the...
【3分で解説 世界のファーマ】第23回 トランプ関税 製薬への影響は (Japanese-language podcast)
07 Mar 2025
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
트럼프의 관세 인상에 대한 엇갈린 반응 (Korean-language podcast)
06 Mar 2025
Contributed by Lukas
트럼프의 관세 조치에 따른 미국시장 영향과 글로벌 빅파마들의 반응에 대한 Scrip 기사를 요약한 내용입니다. http...
The Challenge Of Innovating In A Changing OTC Industry With AdverCheck’s James Walmsley
03 Mar 2025
Contributed by Lukas
The consumer healthcare industry is changing. Companies are separating from their pharmaceutical parents and brands are shifting from therapeutic solu...
Scrip's Five Must-Know Things - 3 March 2025
03 Mar 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 February 2025. In this episode: which big companies fa...
Drug Fix: Laid Off US FDA Staff Called Back, Vaccine Adcomm Cancelled, Lilly’s Manufacturing Push
28 Feb 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs, as well as Medtech Insight Managing E...
Scrip's Five Must-Know Things - 25 February 2025
25 Feb 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 February 2025. In this episode: 2025’S biggest launc...
Why OTC Firms Should Care About Rx Advertising, With AdverCheck’s James Walmsley
24 Feb 2025
Contributed by Lukas
UK law prohibits the advertising of prescription-only medicines. Nevertheless, some online pharmacies are marketing Rx drugs from “skinny jabs” to...
Drug Fix: Understanding the US FDA Layoffs And Their Impact On Industry
21 Feb 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs, as well as...
Scrip's Five Must-Know Things - 18 February 2025
18 Feb 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 February 2025. In this episode: delayed take-off for M...
Drug Fix: RFK’s First Actions, Pitch To Extend Current US FDA User Fee Agreement, More Trump Impacts
14 Feb 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs, and special guest Michael McCaughan of Prevision Policy look at new Health...
Podcast: JPM Tracked and Unpacked
13 Feb 2025
Contributed by Lukas
Citeline’s expert panel of reporters and analysts unpack the biggest deals, trends, and innovations from the JP Morgan Healthcare Conference. Discov...
Scrip이 묻다... 2025년 제약바이오 산업의 미래는? 세계 정치 변화의 영향 (Korean-language podcast)
12 Feb 2025
Contributed by Lukas
트럼프 미 대통령의 재당선과 지정학적 불안요소가 제약바이오 시장과 기업에 어떤 영향을 미칠까? Scrip의 전문가...
Getting Creative In Consumer Health, With All Creative’s Beverley Law
10 Feb 2025
Contributed by Lukas
Creativity can sometimes be about discovering what in retrospect seems obvious, like shoes that are shaped to fit our feet, marketing expert Beverley ...
Scrip's Five Must-Know Things - 10 February 2025
10 Feb 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 February 2025. In this episode: Novo outlines CagriSema...
Drug Fix: Kennedy’s Assurances To Gain HHS Nod, US FDA Coms Freeze Continues Thawing
07 Feb 2025
Contributed by Lukas
Introduction: Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobb...